Physician profile
Heru Wang
NPI 1124857768
$1,259.87
in general payments reported to CMS, 2019-2025
16 companies · $568 in 2025
The $568 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $692 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $199.51 | 2024-2025 | Vemlidy |
| Lilly USA, LLC | $166.14 | 2024-2025 | Mounjaro, Zepbound |
| Agios Pharmaceuticals, INC. | $162.24 | 2024 | Pyrukynd |
| Bayer Healthcare Pharmaceuticals INC. | $146.79 | 2024 | |
| Glaxosmithkline, LLC. | $103.09 | 2024 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $93.77 | 2024-2025 | Tavneos, Repatha |
| Astrazeneca Pharmaceuticals LP | $68.90 | 2024 | Breztri |
| Xeris Pharmaceuticals, INC. | $63.66 | 2024-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $48.83 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $43.40 | 2025 | Rotateq, Capvaxive, Gardasil 9 |
| Otsuka America Pharmaceutical, INC. | $42.35 | 2025 | Rexulti |
| Viatris Specialty LLC | $33.00 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.51 | 2025 | Ofev |
| Vertex Pharmaceuticals Incorporated | $24.90 | 2025 | |
| Sanofi Pasteur INC. | $18.80 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $16.98 | 2025 | Mresvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heru Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.